Could avoiding Pre-Radiation tooth removal protect jaw health?
NCT ID NCT07764887
First seen Aug 14, 2026 ยท Last updated Aug 14, 2026
Summary
This trial asks whether it is safe to skip the routine removal of impacted teeth before radiation therapy for nasopharyngeal carcinoma. Half of the participants will have the extraction as usual, while the other half will not. The study will compare the risk of jaw bone damage (osteoradionecrosis) over two years, along with survival and quality of life, to see if omitting the procedure is a viable option.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Omission of prophylactic impacted tooth extraction before radiotherapy
- What this could lead to
- If skipping the extraction is safe, patients could avoid an unnecessary dental procedure before cancer treatment, reducing discomfort and delays.
- What could go wrong
- The trial is early and noninferiority design; if omission increases jaw bone damage risk, it would be unsafe. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CARCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Youjiang Medical University for Nationalities
Baise City, Guangxi, 533000, China
-
Beihai People's Hospital
Beihai, Guangxi, 536000, China
-
Guigang People's Hospital
Guigang, Guangxi, 537100, China
-
Liuzhou People's Hospital
Liuzhou, Guangxi, 545006, China
-
Liuzhou Workers' Hospital
Liuzhou, Guangxi, 545007, China
-
The Affiliated Hospital of Guilin Medical University
Guilin, Guangxi, 541001, China
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, 530021, China
-
The First People's Hospital of Yulin
Yulin, Guangxi, 537000, China
-
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, 530000, China
-
Wuming Hospital Affiliated to Guangxi Medical University
Nanning, Guangxi, 530199, China
-
Wuzhou Red Cross Hospital
Wuzhou, Guangxi, 543002, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood test and MRI tailor cancer therapy to each patient?
- Can an immunotherapy boost standard treatment for a Head-and-Neck cancer?
- Can a Two-Pronged radiation strategy boost immunotherapy against advanced nasopharyngeal cancer?
- Can tumor genetics predict survival in nasopharyngeal cancer?
- Dual-Action antibody may boost chemoradiotherapy against High-Risk nasopharyngeal cancer
- Could a 'Sandwich' of drugs beat Full-Course immunotherapy for a tough head and neck cancer?